Experimental models and behavioural tests used in the study of Parkinson's disease.

The present review brings the survey of the most frequently used behavioural tests in experimental models of Parkinson's disease (PD). Although there is no spontaneous occurrence of parkinsonism in animals, several experimental animal models of PD have been developed to achieve the same clinical features in animals. The techniques employing neurotoxins in lesioning the nigrostriatal dopaminergic (DA) system have a large selectivity and reproducibility. The most frequently used neurotoxins are 1-methyl-4-phenyl- 1,2,3,6-tetrahydropyridine (MPTP) and 6-hydroxydopamine (6-OHDA). MPTP-lesioned monkeys mimic best the symptomatology of PD in human patients while rats appear to be refractory to MPTP. For that reason, 6-OHDA is used to damage the substantia nigra in a rodent model. Behavioural tests of animals with nigrostriatal lesion represent valuable non-invasive methods for assessing the influence of damaged DA system on locomotor activity. The most frequently used experimental model of PD is the drug-evoked rotation in 6-OHDA unilaterally lesioned rats. This model produces well-defined and stable behavioural deficits. The rotation test is a useful parameter for evaluating imbalances of dopamine in both striata of the hemi-parkinsonian rat model. T-maze, treadmill running test or sensorimotor tests are used to evaluate spontaneous locomotor activity of lesioned animals. Skilled motor tasks measure the influence of dopamine-depleting lesions on complex motor acts. Transplantation of DA tissue into the striatum offers a new approach to the treatment of PD. Experimental models and behavioural tests are used to evaluate the extent of graft-induced recovery of MPTP- or 6-OHDA-lesioned animals. Different results obtained after the use of different tests reflect the level of graft integration into the host circuitry.

[1]  A. Bjo¨rklund,et al.  Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants , 1979, Brain Research.

[2]  U. Ungerstedt,et al.  Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system. , 1971, Acta physiologica Scandinavica. Supplementum.

[3]  J. Coyle,et al.  Oxidative stress, glutamate, and neurodegenerative disorders. , 1993, Science.

[4]  T. Hökfelt,et al.  Specificity of 6-hydroxydopamine induced degeneration of central monoamine neurones: an electron and fluorescence microscopic study with special reference to intracerebral injection on the nigro-striatal dopamine system. , 1973, Brain research.

[5]  S. Dunnett,et al.  The “staircase test”: a measure of independent forelimb reaching and grasping abilities in rats , 1991, Journal of Neuroscience Methods.

[6]  A. Björklund,et al.  Nigral transplants reinnervating the dopamine-depleted neostriatum can sustain intracranial self-stimulation. , 1983, Science.

[7]  C. Marsden,et al.  An immunohistochemical study of the acute and long-term effects of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine in the marmoset , 1987, Neuroscience.

[8]  I. Whishaw,et al.  Dopamine-rich grafts ameliorate whole body motor asymmetry and sensory neglect but not independent limb use in rats with 6-hydroxydopamine lesions , 1987, Brain Research.

[9]  S. Iversen,et al.  Behavioural recovery following transplantation of substantia nigra in rats subjected to 6-OHDA lesions of the nigrostriatal pathway. I. Unilateral lesions , 1981, Brain Research.

[10]  J. Sagen,et al.  Robust survival of isolated bovine adrenal chromaffin cells following intrastriatal transplantation: a novel hypothesis of adrenal graft viability , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[11]  U. Ungerstedt.  Adipsia and aphagia after 6-hydroxydopamine induced degeneration of the nigro-striatal dopamine system. , 1971, Acta physiologica Scandinavica. Supplementum.

[12]  H. Imai.  [MPTP and Parkinson's disease]. , 1988, No to shinkei = Brain and nerve.

[13]  O. Lindvall.  Prospects of transplantation in human neurodegenerative diseases , 1991, Trends in Neurosciences.

[14]  D. Jacobowitz,et al.  A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[15]  J. Fawcett,et al.  Basic fibroblast growth factor promotes the survival of embryonic ventral mesencephalic dopaminergic neurons--II. Effects on nigral transplants in vivo. , 1993, Neuroscience.

[16]  J. C. Stoof,et al.  12 - Unilateral MPTP-Lesioned Monkey as an Animal Model for Parkinson's Disease , 1991 .

[17]  H. Nishino,et al.  Treadmill running test for evaluating locomotor activity after 6-OHDA lesions and dopaminergic cell grafts in the rat , 1993, Brain Research Bulletin.

[18]  J. Bureš,et al.  Asymmetry of EEG arousal in rats with unilateral 6-hydroxydopamine lesions of substantia nigra: Quantification of neglect , 1978, Experimental Neurology.

[19]  Anders Björklund.  Neural transplantation — an experimental tool with clinical possibilities , 1991, Trends in Neurosciences.

[20]  A. Björklund,et al.  Reinnervation of the denervated striatum by substantia nigra transplants: Functional consequences as revealed by pharmacological and sensorimotor testing , 1980, Brain Research.

[21]  B J Hoffer,et al.  Brain grafts reduce motor abnormalities produced by destruction of nigrostriatal dopamine system. , 1979, Science.

[22]  A. Björklund,et al.  Host Brain Regulation of Fetal Locus Coeruleus Neurons Grafted to the Hippocampus in 6‐Hydroxydopamine‐Treated Rats. An Intracerebral Microdialysis Study , 1991, The European journal of neuroscience.

[23]  G. Cohen,et al.  Inhibition of Biogenic Amine Uptake by Hydrogen Peroxide: A Mechanism for Toxic Effects of 6-Hydroxydopamine , 1971, Science.

[24]  P. Teitelbaum,et al.  Further analysis of sensory inattention following lateral hypothalamic damage in rats. , 1974, Journal of comparative and physiological psychology.

[25]  S. Iversen,et al.  Behavioural recovery following transplantation of substantia nigra in rats subjected to 6-OHDA lesions of the nigrostriatal pathway. II. Bilateral lesions , 1981, Brain Research.

[26]  U. Ungerstedt,et al.  6-Hydroxy-dopamine induced degeneration of central monoamine neurons. , 1968, European journal of pharmacology.

[27]  J. Marshall.  Somatosensory inattention after dopamine-depleting intracerebral 6-OHDA injections: Spontaneous recovery and pharmacological control , 1979, Brain Research.

[28]  U. Ungerstedt,et al.  Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. , 1970, Brain research.

[29]  K. Bankiewicz.  MPTP-Induced Parkinsonism in Nonhuman Primates , 1991 .

[30]  T. Sourkes,et al.  INFLUENCE OF THE SUBSTANTIA NIGRA ON THE CATECHOLAMINE CONTENT OF THE STRIATUM. , 1965, Brain : a journal of neurology.